ArticleClinical and experimental immunology2008

Non-response to infliximab may be due to innate neutralizing anti-tumour necrosis factor-alpha antibodies.

E C Ebert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.